pETM33_Nsp5_Mpro Citations (4)

Originally described in: Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.
Mihalic F, Benz C, Kassa E, Lindqvist R, Simonetti L, Inturi R, Aronsson H, Andersson E, Chi CN, Davey NE, Overby AK, Jemth P, Ivarsson Y Nat Commun. 2023 Sep 13;14(1):5636. doi: 10.1038/s41467-023-41312-8. PubMed Journal

---

Articles Citing pETM33_Nsp5_Mpro

Articles
Structure-Based Virtual Screening and Functional Validation of Potential Hit Molecules Targeting the SARS-CoV-2 Main Protease. Moovarkumudalvan B, Geethakumari AM, Ramadoss R, Biswas KH, Mifsud B. Biomolecules. 2022 Nov 25;12(12):1754. doi: 10.3390/biom12121754. PubMed
Inhibition of SARS-CoV-2 M(pro) with Vitamin C, L-Arginine and a Vitamin C/L-Arginine Combination. Dukic I, Kalicanin N, Sencanski M, Pajovic SB, Milicevic J, Prljic J, Paessler S, Prodanovic R, Glisic S. Front Biosci (Landmark Ed). 2023 Jan 13;28(1):8. doi: 10.31083/j.fbl2801008. PubMed
Protegrin-2, a potential inhibitor for targeting SARS-CoV-2 main protease M(pro). Jan Z, Geethakumari AM, Biswas KH, Jithesh PV. Comput Struct Biotechnol J. 2023 Jul 24;21:3665-3671. doi: 10.1016/j.csbj.2023.07.020. eCollection 2023. PubMed
Improved expression and purification of highly-active 3 chymotrypsin-like protease from SARS-CoV-2. Nguyen HT, Nguyen NT, Le TT, Pham XT, Pham HL, Le HT, Phan TN, Dinh NT. Protein Expr Purif. 2024 Mar;215:106414. doi: 10.1016/j.pep.2023.106414. Epub 2023 Dec 9. PubMed

If you have published an article using this material, please email us at to have your article added to this page.